StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) stock

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.25−0.01 (-0.31%)

Close on Nov 18, 2026Market cap $23.95MP/E –Yield –

Immutep net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2026 it was -A$79.30M. The highest annual figure on record is -A$9.37M in fiscal 2017.

Annual net income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$79.30M–
FY2025Jun 30, 2025-A$61.43M–
FY2024Jun 30, 2024-A$42.72M–
FY2023Jun 30, 2023-A$39.90M–
FY2022Jun 30, 2022-A$32.21M–
FY2021Jun 30, 2021-A$29.90M–
FY2020Jun 30, 2020-A$13.47M–
FY2019Jun 30, 2019-A$18.34M–
FY2018Jun 30, 2018-A$12.75M–
FY2017Jun 30, 2017-A$9.37M–
FY2016Jun 30, 2016-A$62.02M–

More Immutep figures

See a number that looks wrong?